Annelie Linjer Palm

Annelie Linjer Palm is a skilled professional in the pharmaceutical and biotechnology sectors with extensive experience in hematology and product management. Currently serving as Product Manager for Haemophilia in the Nordic and Baltic countries at Sobi - Swedish Orphan Biovitrum AB since July 2022, Annelie has previously held key managerial roles at Takeda, Shire, and Vifor Pharma, focusing on brand management and key account management. Annelie's career also includes leadership positions in project management and sales at companies such as NordicInfu Care AB, Fresenius Medical Care, and Serono Nordic AB, along with entrepreneurial experience as the owner of Alomnia AB. Annelie Linjer Palm’s comprehensive background encompasses a commitment to improving patient outcomes in hematology through strategic engagement and innovative product solutions.